Antibodies and DNA used to find the biological markers of disease.

Almost 1 million Americans suffer from MS.

The team acknowledges the challenges in realizing this potential, particularly the standardization of urinary biomarker assays and the expansion of the spectrum of diseases that...

Novel computational model predicts significant irAEs in NSCLC patients based on proteomic profiling of one pre-treatment blood test.

New deep brain stimulation device coupled with powerful AI may improve therapy for treatment-resistant depression.

The review article, “The Potential of Blood Neurofilament Light as a Marker of Neurodegeneration in Alzheimer’s disease,” is published in the journal Brain.

As laboratory assays have evolved with improved performance, the clinical use of cardiac troponin (cTn) has also evolved beyond the context of myocardial infarction (MI). The ...

MS research.

Study led by Johns Hopkins Medicine in collaboration with Yale School of Medicine.

Walking up the stairs had become difficult for Louise, an otherwise healthy, active, and stubborn 85-year-old retired nurse. It was spring, and Louise figured that she was deconditioned...